• GLP-1R is abundantly expressed in lung epithelia and certain immune cells. • GLP-1 based drugs show “therapeutic effects” in acute and chronic lung injury models. • Clinical trial is designed in testing effect of GLP-1 analogues in treating Covid-19. • Retrospective studies should be conducted in T2D subject with Covid-19.